Crossmark

Combinatorial phenethyl isothiocyanate and withaferin A targets multiple epigenetics pathways to inhibit MCF-7 and MDA-MB-231 human breast cancer cells

Crossref DOI link: https://doi.org/10.1186/s12935-024-03619-4

Published Online: 2024-12-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rahman, Mohammad Mijanur

Tollefsbol, Trygve O.
Funding

Funding for this research was provided by:

National Institutes of Health (NCI R01 CA178441)

National Institutes of Health, United States (R01 CA204346)
License Information

Text and Data Mining valid from 2024-12-20

Version of Record valid from 2024-12-20
More Information

Article History

Received: 15 April 2024

Accepted: 14 December 2024

First Online: 20 December 2024

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below